Home › Uterine Fibroids › NCT06135870
Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)
RecruitingObservational study
Role of Senescent Cells in Uterine Fibroid Pathogenesis
Who can join
Ages 18 to 55 · Women
Full eligibility criteria
Inclusion Criteria: * Subjects must be women above the age of ≥18 - ≤55 years. * Women with suspected uterine fibroids. * Subject must be or have been sexually active or have had a previous vaginal exam that used a speculum. * Subject must be able to understand, read and speak English or Spanish and subsequently, be able to understand what she is consenting to in terms of procedures and use/disclosure of protected health information. Exclusion Criteria: * Unwilling to sign the consent form or complete questionnaire. * Pregnancy. * Cancer of the uterus
About the study
The investigators are evaluating the role of senescent cells in uterine fibroids.
Sponsor: Johns Hopkins University · Participants: 150 · Started: Nov 1, 2023
Contact the study team
- James Segars, MD · Phone: 410-614-2000
- Bhuchitra Singh, MD, MPH, MBA · Phone: 410-614-2000
Official record on ClinicalTrials.gov — NCT06135870
Locations in the U.S.
| Maryland | Johns Hopkins Hospital, Baltimore |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.